|

NBM-BMX Capsule Clinical Trials

2 actively recruiting trials

▲ +1 trial since May 2026

Pipeline

Phase 1/2: 2

Top Sponsors

  • Novelwise Pharmaceutical Corporation2

Indications

  • Malignant Neoplasm of Brain2
  • Cancer2
  • Malignant Neoplasm1

Other2 trials

A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma
Phase 1/2
NBM-BMX Administered Orally to Patients With Solid Tumors or Newly Diagnosed Glioblastoma
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.